Navigation Links
Final agenda available for CRF Conference on Stem Cell Therapy for Heart Disease
Date:1/8/2014

WHAT:

The final agenda for the Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online at http://www.crf.org/celltherapy/the-conference/agenda. The conference, which will be held January 22-24, 2014, is the premier meeting dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

This year's conference will focus on preclinical and clinical studies and their paths toward optimizing outcomes. The most promising molecular, cellular, and tissue products will be presented. Presentations of key activities at state, federal, and international levels will also be highlighted as measures of the progress ahead.

WHY:

Recent advances in stem cell research demonstrate great potential as breakthrough therapies for conditions like diabetes, Parkinson's and heart disease. Now in its 13th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has provided both a strong foundation for the conduct of large scale, pivotal studies, as well as insights into mechanisms of cardiovascular repair that will enhance the design of further investigation.

Renowned thought leaders in this field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies. Sessions will focus on:

  • Molecular and Cellular Pathways: Regulating Biologic Function
  • Mechanistic Insights and Hypothesis
  • Moving Toward Tissue as Therapy: Micro- and Macro-Structure Strategies
  • STEMI and Acute Injury Studies
  • Chronic Injury and Vascular Insufficiency
  • Chronic Left Ventricular Dysfunction and Heart Failure
  • Patients-In-Need: Defining and Refining our Approach to Target Populations
  • Data in Hand: Looking for Answers in Meta-Analytic Studies
  • Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine

WHO:

Course Director

Warren Sherman, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Course Co-Directors

Jozef Bartunek, MD, PhD

Henricus J. Duckers, MD, PhD

Amit Patel, MD, MS

Marc S. Penn, MD, PhD

Thomas Povsic, MD

Gordana Vunjak-Novakovic, PhD

Joseph Wu, MD, PhD

Wojtek Wojakowski, MD, PhD

WHEN:

January 22-24, 2014

WHERE:

Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

For more information visit: http://www.crf.org/celltherapy.

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related biology news :

1. Planet under Pressure conference, London: Final statement
2. Sequencing works in clinical setting to help -- finally -- get a diagnosis
3. NYBG press publishes final volume of landmark Intermountain Flora series
4. Finalists of air pollution sensor challenge announced
5. Dark matter made visible before the final cut
6. Researchers attack HIVs final defenses before drug-resistant mutations emerge
7. WPI Biomedical Technology in final 4 of international business plan contest
8. Final chapter to 60-year-old blood group mystery
9. Fueling fitness on the final frontier
10. Finally mapped: The brain region that distinguishes bits from bounty
11. The Sackler Institute unveils a global research agenda for nutrition science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2016)... March 9, 2016 Nigeria ... that more than 23,000 public service employees either did ... receiving their salary unlawfully.    --> ... identified that more than 23,000 public service employees either ... been receiving their salary unlawfully.    --> ...
(Date:3/3/2016)... Calif. , March 3, 2016  FlexTech, a ... the categories of Innovation, Research & Development, Leadership in ... Leadership. This is the 9 th year of ... group of companies and individuals from past years ... based on a pre-described set of criteria, by a ...
(Date:3/2/2016)... , March 2, 2016 ... announced the addition of the  "Global Biometrics ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... to grow at a CAGR of around ... ) has announced the addition of ...
Breaking Biology News(10 mins):
(Date:5/2/2016)... ... ... StarNet Communications Corp, ( http://www.starnet.com/ ) a leading publisher of remote Linux and ... its flagship X-Win32 PC X server. The new modules enable X-Win32 to safely ... encrypted SSH. , Traditionally, users of PC X servers deploy the XDMCP protocol to ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... personalized pain medicine, is excited to announce the launch of the Proove ... health studies, volunteerism, and education to promote the use of personalized medicine for ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... to transform technology into a viable company, CereScan’s CEO, John Kelley, joined other ... a recognized leader and mentor in the Denver area business community, shared his ...
(Date:4/29/2016)... 29, 2016 Elekta is pleased ... to its industry-leading treatment planning software, is available for ... Monaco version 5.11 provides significant performance speed ... speeds up to four times faster than in previous ... industry,s gold standard Monte Carlo ...
Breaking Biology Technology: